4.2 Article

Inducible, tightly regulated and non-leaky neuronal gene expression in mice

期刊

TRANSGENIC RESEARCH
卷 23, 期 2, 页码 225-233

出版社

SPRINGER
DOI: 10.1007/s11248-013-9767-7

关键词

TET system; Transgenic mice; Doxycycline; LacZ reporter; Leakage; Thy1.2 promoter

资金

  1. National Health & Medical Research Council (NHMRC, Australia)
  2. Australian Research Council (ARC)
  3. Alzheimer Association (US)
  4. Alzheimer's Australia
  5. Jane Mason and Harold Stannett Williams Memorial Foundation (Australia)
  6. Phillip Jacoby Scholarship in Alzheimer's Dementia Research
  7. Rheumatic Disease Core Center

向作者/读者索取更多资源

The Tetracycline (Tet)-controlled inducible system is the most widely used reversible system for transgene expression in mice with over 500 lines created to date. Although this system has been optimized over the years, it still has limitations such as residual transgene expression when turned off, referred to as leakiness. Here, we present a series of new Tet-OFF transgenic mice based on the second generation tetracycline-responsive transactivator system. The tTA-Advanced (tTA2(S)) is expressed under control of the neuron-specific Thy1.2 promoter (Thy-OFF), to regulate expression in the mouse brain. In addition, we generated a lacZ reporter line, utilizing the P (tight) Tet-responsive promoter (P (tight)-lacZ), to test our system. Two Thy-OFF transgenic lines displaying two distinct patterns of expression were selected. Oral doxycycline treatment of Thy-OFF/P (tight)-lacZ mice demonstrated tight transgene regulation with no leak expression. These new Thy-OFF mice are valuable for studies in a broad range of neurodegenerative diseases such as Alzheimer's disease and related forms of dementia, where control of transgene expression is critical to understanding mechanisms underlying the disease. Furthermore, P (tight)-lacZ reporter mice may be widely applicable.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.2
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Behavioral Sciences

Cannabidiol (CBD) treatment improves spatial memory in 14-month-old female TAU58/2 transgenic mice

Fabian Kreilaus, Magdalena Przybyla, Lars Ittner, Tim Karl

Summary: This study investigated the therapeutic effects of CBD on transgenic mice and found that CBD can improve behavioural deficits and cognitive impairments associated with FTD and AD.

BEHAVIOURAL BRAIN RESEARCH (2022)

Article Chemistry, Multidisciplinary

The Nature of Diamino Linker and Halogen Bonding Define Selectivity of Pyrrolopyrimidine-Based LIMK1 Inhibitors

Daryl Ariawan, Carol Au, Esmeralda Paric, Thomas Fath, Yazi D. Ke, Michael Kassiou, Janet van Eersel, Lars M. Ittner

Summary: The LIMK family, including LIMK1 and LIMK2, plays a key role in regulating actin cytoskeleton dynamics. By designing and synthesizing analogues with different stereochemistry, the study aimed to improve selectivity for different LIMK isoforms. Changes in stereochemistry were found to impact LIMK isoform selectivity, with docking studies predicting interactions with the target.

FRONTIERS IN CHEMISTRY (2021)

Review Clinical Neurology

Biomarker discovery and development for frontotemporal dementia and amyotrophic lateral sclerosis

Jared S. Katzeff, Fiona Bright, Katherine Phan, Jillian J. Kril, Lars M. Ittner, Michael Kassiou, John R. Hodges, Olivier Piguet, Matthew C. Kiernan, Glenda M. Halliday, Woojin Scott Kim

Summary: This study explores and evaluates potential biomarkers for distinguishing frontotemporal dementia and amyotrophic lateral sclerosis, aiming to improve diagnosis and treatment for patients. The two diseases share common genetic and molecular features, with a lack of sensitive and specific biomarkers for diagnostic and disease surveillance purposes.
Article Multidisciplinary Sciences

Differential mitochondrial protein interaction profile between human translocator protein and its A147T polymorphism variant

Prita R. Asih, Anne Poljak, Michael Kassiou, Yazi D. Ke, Lars M. Ittner

Summary: The translocator protein (TSPO) plays a role in mitochondrial cholesterol transport, brain inflammation, and other mitochondrial functions. A common A147T polymorphism in TSPO reduces ligand binding and is associated with increased risk of neuropsychiatric disorders. This study found that the A147T polymorphism has fewer binding partners compared to the wild-type TSPO, suggesting a loss of function in mitochondrial protein networks.

PLOS ONE (2022)

Article Clinical Neurology

Loss of LAMP5 interneurons drives neuronal network dysfunction in Alzheimer's disease

Yuanyuan Deng, Mian Bi, Fabien Delerue, Shelley L. Forrest, Gabriella Chan, Julia van der Hoven, Annika van Hummel, Astrid F. Feiten, Seojin Lee, Ivan Martinez-Valbuena, Tim Karl, Gabor G. Kovacs, Grant Morahan, Yazi D. Ke, Lars M. Ittner

Summary: In Alzheimer's disease, hyperexcitation of neuronal networks is an underlying disease mechanism. The study identifies LAMP5 as a novel regulator of hyperexcitation in mice, critical for the survival of distinct interneuron populations.

ACTA NEUROPATHOLOGICA (2022)

Article Cell Biology

Efficient Gene Expression in Human Stem Cell Derived-Cortical Organoids Using Adeno Associated Virus

Ann-Na Cho, Fiona Bright, Nicolle Morey, Carol Au, Lars M. Ittner, Yazi D. Ke

Summary: Cortical organoids derived from human stem cells are three-dimensional structures capable of better simulating the human brain. Adeno-associated viruses (AAVs) have emerged as a vector of choice for gene therapy targeting the central nervous system. In this study, AAVs were compared to traditional methods for gene expression in cortical organoids, and it was demonstrated that AAVs can easily generate disease models through the expression of different variants of the central gene TDP-43, implicated in neurodegenerative diseases.
Article Biochemistry & Molecular Biology

Understanding In Vitro Pathways to Drug Discovery for TDP-43 Proteinopathies

Hei W. A. Cheng, Timothy B. Callis, Andrew P. Montgomery, Jonathan J. Danon, William T. Jorgensen, Yazi D. Ke, Lars M. Ittner, Eryn L. Werry, Michael Kassiou

Summary: The use of cellular models in drug discovery for ALS and FTD is common, but there is currently no consensus on the most accurate model to replicate key pathological features. This study characterized two TDP-43 proteinopathy cellular models and found that different effects were observed when small molecule probes were exposed to these models. The study highlights the challenges of using cellular models in lead development and emphasizes the need for evaluations of novel therapeutics across various cell lines and aetiological models.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Multidisciplinary Sciences

Treatment of epilepsy using a targeted p38y kinase gene therapy

Nicolle Morey, Magdalena Przybyla, Julia van der Hoven, Yazi D. Ke, Fabien Delerue, Janet van Eersel, Lars M. Ittner

Summary: Hyperphosphorylated tau protein is involved in various neurological disorders, while site-specific phosphorylation of tau at T205 by p38y kinase can protect against Alzheimer's disease. Delivery of p38y through gene transfer reduces seizure susceptibility, restores normal neuronal activity, improves behavioral deficits, and prevents epilepsy-induced deaths. Additionally, p38y-mediated phosphorylation of tau at T205 plays a crucial role in protecting against epilepsy.

SCIENCE ADVANCES (2022)

Article Clinical Neurology

Cell-specific MAPT gene expression is preserved in neuronal and glial tau cytopathologies in progressive supranuclear palsy

Shelley L. Forrest, Seojin Lee, Nasna Nassir, Ivan Martinez-Valbuena, Valerie Sackmann, Jun Li, Awab Ahmed, Maria Carmela Tartaglia, Lars M. Ittner, Anthony E. Lang, Mohammed Uddin, Gabor G. Kovacs

Summary: MAPT protein aggregates in neurons, astrocytes and oligodendrocytes in neurodegenerative diseases, and this study found that cytopathology of tau does not compromise MAPT expression. The results suggest a dual approach to therapy by decreasing cellular MAPT expression and targeting removal of misfolded tau.

ACTA NEUROPATHOLOGICA (2023)

Article Clinical Neurology

TDP-43 pathology and functional deficits in wild-type and ALS/FTD mutant cyclin F mouse models

Annika van Hummel, Miheer Sabale, Magdalena Przybyla, Julia van der Hoven, Gabriella Chan, Astrid F. Feiten, Roger S. Chung, Lars M. Ittner, Yazi D. Ke

Summary: This study developed the first mouse models expressing wild-type and mutant human CCNF genes to replicate the key clinical and neuropathological features of ALS and FTD linked to CCNF disease variants. The results showed that these mice exhibited behavioral abnormalities similar to FTD patients, as well as memory deficits. Furthermore, the study found altered CCNF-mediated pathways and abnormal TDP-43 neuropathology, which are key hallmarks of FTD/ALS pathology.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Clinical Neurology

Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy

Annika van Hummel, Goce Taleski, Jean-Marie Sontag, Astrid Feentje Feiten, Yazi D. Ke, Lars M. Ittner, Estelle Sontag

Summary: Experimental evidence shows that dietary supplementation with L-methylfolate, choline, and betaine can reduce phosphorylation of tau protein and alleviate associated behavioral and learning deficits. This change is associated with increased methylation of protein phosphatase 2A and decreased levels of Fyn, a tau tyrosine kinase. Enhancing one-carbon metabolism may be a potential treatment for tauopathies.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Article Clinical Neurology

Methyl donor supplementation reduces phospho-Tau, Fyn and demethylated protein phosphatase 2A levels and mitigates learning and motor deficits in a mouse model of tauopathy

Annika van Hummel, Goce Taleski, Jean-Marie Sontag, Astrid Feentje Feiten, Yazi D. Ke, Lars M. Ittner, Estelle Sontag

Summary: In this study, it was found that dietary supplementation with L-methylfolate, choline, and betaine can reduce phosphorylation of tau protein and associated behavioral phenotypes in the TAU58/2 mouse model. These findings provide experimental evidence that boosting one-carbon metabolism may be a potential therapeutic strategy for tauopathies.

NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY (2023)

Review Materials Science, Biomaterials

Recent progress in synthetic self-adjuvanting vaccine development

Daryl Ariawan, Janet van Eersel, Adam D. Martin, Yazi D. Ke, Lars M. Ittner

Summary: This paper summarizes different self-adjuvant structures, including self-assembly peptides, lipids, glycolipids, and polymers, which enhance the immune response to peptide or small molecule antigens.

BIOMATERIALS SCIENCE (2022)

暂无数据